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Alteration in Fluidity of Cell Plasma 
Membrane in Huntington Disease 
Revealed by Spectral Phasor 
Analysis
Sara Sameni1,2, Leonel Malacrida1,2,3, Zhiqun Tan4 & Michelle A. Digman1,2
Huntington disease (HD) is a late-onset genetic neurodegenerative disorder caused by expansion of 
cytosine-adenine-guanine (CAG) trinucleotide in the exon 1 of the gene encoding the polyglutamine 
(polyQ). It has been shown that protein degradation and lipid metabolism is altered in HD. In many 
neurodegenerative disorders, impaired lipid homeostasis is one of the early events in the disease onset. 
Yet, little is known about how mutant huntingtin may affect phospholipids membrane fluidity. Here, 
we investigated how membrane fluidity in the living cells (differentiated PC12 and HEK293 cell lines) 
are affected using a hyperspectral imaging of widely used probes, LAURDAN. Using phasor approach, 
we characterized the fluorescence of LAURDAN that is sensitive to the polarity of the immediate 
environment. LAURDAN is affected by the physical order of phospholipids (lipid order) and reports 
the membrane fluidity. We also validated our results using a different fluorescent membrane probe, 
Nile Red (NR). The plasma membrane in the cells expressing expanded polyQ shows a shift toward 
increased membrane fluidity revealed by both LAURDAN and NR spectral phasors. This finding brings 
a new perspective in the understanding of the early stages of HD that can be used as a target for drug 
screening.
One of the common characteristic of neurodegenerative diseases is the aggregation of specific proteins that leads 
to deposits in tissue or subcellular compartments. This is commonly known as protein misfolding or confor-
mational disorder in Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington disease (HD) and other 
neurodegenerative disorders1. HD is a progressive genetic neurodegenerative disorder with complex pathogenies 
including protein aggregation and dysregulation of lipid homeostasis. The key event in such pathologies is the 
conversion of protein to an abnormal conformation that may lead to formation of toxic aggregates. In the case 
of HD, polyglutamine (PolyQ) aggregation is the hallmark of the disease. In the last decades, there has been 
an intense research effort to determine the toxicity of the aggregate species as protein aggregation progresses 
from monomeric to oligomeric and finally a mature inclusion2,3. This understanding is relevant since there are 
currently no effective measures or treatments of HD. Recent research shows that metabolism is also affected as a 
results of HD and indicates disturbed OXPHOS pathway and a shift of the metabolism toward more free NADH 
as the disease progresses that implies disruption of glucose uptake in HD cells compared to normal4.
Besides glucose, lipid metabolism is also shown to be affected in HD and other neurodegenerative disor-
ders5–8. Lipid and cholesterol are important cell plasma membrane components as they control normal cell 
function. In Alzheimer disease (AD), impaired lipid homeostasis is one of the early event in the disease9. The 
alteration in lipid composition can lead to instability in membrane and synaptic loss in AD8. Furthermore, rising 
evidence indicates that altered lipid metabolism is linked to dysfunction in HD5. In particular, research in animal 
and human indicates that cholesterol metabolism is disturbed in HD10. However, the specific alteration remains 
controversial. In normal condition, sterol regulatory element binding protein, SREBPs, regulate lipid homeostasis 
by sensing the level of cholesterol in the cell and provides negative feedback in synthesizing more cholesterol. 
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Upon activation, SREBP acts as transcriptional factor and stimulates expression of enzymes that regulate the 
fatty acid biosynthesis pathway11. Some evidence indicates up to 50% reduction in active SREBP in both HD cells 
and mouse brain tissue10. This can be implicated in HD pathogenesis by reduced biosynthesis of cholesterol and 
fatty acids. Other evidence also show the slower growth of skin fibroblasts of HD patients compared to normal 
when they are treated with lipid deprived medium5. However, other studies suggest accumulation of cholesterol 
as a results of dysfunction in the transport of cholesterol due to mutant huntingtin interaction with Caveolin-
1(vesicles transporting cholesterol through membranes)12.
Given that there is a perturbation in biosynthesis of fatty acid or disruption of transport mechanisms of lipid 
in HD, in this paper we aim to address how membrane fluidity is affected in HD. For this characterization, we 
used two distinct fluorescent probes: LAURDAN and Nile Red. Both dyes are commonly used for membrane 
phase characterizations13,14. These probes are sensitive to the polarity of the environment since their emission 
and lifetimes shift toward shorter wavelength and longer lifetime with decreasing solvent polarity15–17. On the 
other hand, in the apolar solvents, the emission of these probes are blue shifted. LAURDAN, 6-dodecanyl-2
-dimethylaminonaphthalene, was first developed by Gregorio Weber18. It is a common dye used to study mem-
brane fluidity defined as changes in the lipid order as it senses the water penetration into the membrane19,20. 
Nile red (NR), 9-diethylamino-5H-benzo[alpha]phenoxazine-5-one, is another lipophilic stain that has been 
successfully used to label lipid droplets21,22, to characterize total lipid content23, and also to study membrane 
organization24,25. NR is an uncharged red phenoxazone dye and its fluorescence emission is altered based on the 
immediate environmental properties and a change in the dipole moment upon excitation26,27.
We used aforementioned dyes and a powerful fit-free approach based on spectral shifts analyzed with the spec-
tral phasor approach to map membrane fluidity in living cells as opposed to the traditional method using normal-
ized ratio-metric assay known as generalized polarization, GP28–30. The method and technique presented here has 
the advantage of analyzing the fluorescently tagged cells, and can detect contribution of multi-components emis-
sions compared to the GP approach. This method was used in two different cell lines, HEK 293 and differentiated 
PC12, where expanded polyQ HTT exon 1 was tagged with different fluorescent proteins (EGFP and mRuby). We 
detected membrane fluidity changes by the combining spectral phasor analysis and solvatochromic dyes related 
to liquid disordered (Ld) and liquid ordered (Lo) phases. Our analysis indicates increased membrane fluidity and 
shift toward Ld phase when expanded polyQ was expressed. This approach can open up new frontiers to evaluate 
the efficacy of treatments in HD or other similar neurodegenerative disorders.
Materials and Methods
Spectral image acquisition was achieved using the 32 channel QUASAR multispectral scanning module on 
the Zeiss LSM710 laser scanning microscope (Carl Zeiss, Jena, Germany) equipped with Ti: Sapphire laser 
(Spectra-Physics Mai Tai, Newport Beach, CA) and 63× NA 1.4 oil objective. For each experiment, cells were first 
visualized using either 488 nm or 561 nm excitation, with respective bandpass filters, to excite either green fluo-
rescent protein (EGFP) or mRuby with the single channel PMT detector. For LAURDAN experiment, we used 
a 405 nm and 561 nm laser lines to excite LAURDAN and mRuby, respectively. Figure S1 shows a cartoon rep-
resentation of LAURDAN in the membrane. Nile red was then used separately as a sensor to characterize mem-
brane fluidity in the cells with EGFP labeled HTT protein stained with Nile Red (NR). We employed 2-photon 
(2-PE) excitation microscopy by setting the excitation wavelength to 950 nm to co-excite NR and EGFP. For all 
experiments, spectral images were acquired using the lambda mode 32 channels from 416 nm to 728 nm and a 
bandwidth of 9.78 nm. The frame resolution was set to 256 × 256 pixels and with a pixel dwell time of 12.61μs/
pixel. All data were analyzed using SimFCS software available at (www.lfd.uci.edu). All cells were maintained at 
37 °C and 5% CO2 during imaging.
Spectral Phasor Plot and Linear Combination Rule. Here we employed an elegant way to separate 
fluorescently tagged protein signal from LAURDAN signal in living cells using a fit-free spectral phasor analysis 
(Fig. 1).
Spectral phasor analysis is based on the Fourier transformation (shown in equations 1 and 2) of the fluo-
rescence emission spectra (in this case wavelength range is 416 nm to 728 nm) obtained from at each pixel in 
the hyperspectral image using the 32 channels detector of the Zeiss LSM 71013,17. In the equations 1 and 2, I (λ) 
represents intensity at each spectral step, n is the harmonic number (1 for the data shown in this paper), L is the 
spectrum range (λmax − λmin):
λ
λ
=
∑
∑
λ
pi λ
λ
( )
G
I
I
( )cos
( ) (1)
n
L
2
λ
λ
=
∑
∑
λ
pi λ
λ
( )
S
I
I
( )sin
( ) (2)
n
L
2
By applying the spectral phasor transformation, we produce a polar plot with a single spot for each pixel. In 
this case, the emission spectra at each pixel are transformed into two parameters called G and S (real and imagi-
nary component of the Fourier transformation, see equations 1 and 2), and then plotted in a four-quadrant polar 
plot, called spectral phasor plot, as it shown in Fig. 1B.
Using the phasor approach, we can resolve small spectral shifts on LAURDAN labeled cells that are induced 
due to changes in the membrane microenvironment even in the presence of fluorescent proteins. The phasor 
is calculated over a finite wavelength range. The position of the phasor coordinates will change if the emission 
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spectra is truncated as shown in the emission spectral for (Lo and Ld) LAURDAN (Fig. 1A). In the calculations of 
the Fourier transformation, we used spectra data of a specified wavelength range (416–728 nm). Since all the data 
has the same wavelength emission range, the comparison between all the experiments are valid. However, if the 
wavelength emission range is changed the data are no longer comparable. More importantly, the rule of the linear 
combination of the phasors is not affected by the truncation.
As it is depicted in Fig. 1B the LAURDAN spectral phasors are shown in an ellipsoid with color changing from 
blue to green that indicates a low or high polarity environment respectively. In cells stained with LAURDAN, if 
there is a third fluorescent component in the same pixel indicated by the red dot in Fig. 2B, the position of the 
phasor at that pixel should fall on the dashed lines that joins the LAURDAN trajectory and the fluorescent pro-
tein (in this case mRuby) which defines the linear combination. Using linear combination rule, we can resolve 
complex combinations and characterize membrane fluidity independent of the spectral contamination due to the 
other fluorescent labels or fluorescent proteins. In this case, blue indicates liquid ordered membrane (Lo) with 
highly packed phospholipids, and a shift toward green indicates loosely packed liquid disordered (Ld) phase. 
The penetration of water molecules in the membrane directs the dipolar relaxation of the LAURDAN. Due to 
the complex deexcitation mechanism of LAURDAN, the spectral phasor analysis provides a better interpretation 
of fluorescence emission of LAURDAN at the membrane interface compared to classical GP analysis. Note that 
the LAURDAN spectrum cannot be determined due to the dipolar relaxation effect so that spectral demixing 
methods cannot be applied in this situation. However, the phasor approach can separate the LAURDAN spectral 
position from the contribution of the fluorescent proteins by a simple graphical construction.
Sample Preparation. The stabilized inducible cell model of HD, previously established Htt14A2.6 PC12 
cells, as well as newly generated PC12 cells that inducibly express HTT exon 1 containing either 25Q or 97Q 
repeats fused at C-terminus to EGFP or mRuby were propagated as previously described31,32. For differentia-
tion process, cells were supplemented with reduced levels of fetal bovine serum (FBS, 4% or lower) and plated 
on poly-L-lysine coated glass bottom dish. Neuronal differentiation was induced using 50 ng/ml NGF (Harlan 
Bioproducts for Science, Inc., Madison, WI) for 7–10 days. Cells were induced with 5 μM ponasterone A (PA) to 
induce expression of HTT exon fusion proteins 48 hours prior to the imaging.
HEK 293 (ATCC® CRL-1573™) cells were plated on 35 mm glass bottom dish (MatTek, Ashland, MA) that 
was previously coated with 3ug/ml fibronectin. Cells were transfected overnight using Lipofectamine 2000 
(Invitrogen, Carlsbad, CA) and according to manufacturer’s protocol. Transfection was performed with Httex1p 
97Q-EGFP, Httex1p25Q-EGFP (kindly provided by Thompson L.M., UC Irvine) or EGFP alone. Cells were then 
stained with 1 μM NR and incubated at 37 degree for 5 to 10 min followed by imaging.
LAURDAN and NR were used at final concentration of 1.0 μM in the medium for the cell staining.
For cholesterol depletion study, first cells were grown to 70% confluency. Cholesterol was depleted by 
Methyl-beta-cyclodextrin (MβCD) extracts (Sigma). Cells medium were aspirated, and cells were treated with 
Opti-MEM™ I (ThermoFisher) Reduced-Serum Medium buffered with HEPES and total final concentration 
10 mM of MβCD. Spectral images were then followed immediately by the treatments (every 2–5 min) for 45 min.
GUV preparation. Giant unillamelar vesicles (GUVs) were prepared follow the electroformation protocol 
described by Angelova et al.33. Briefly, dioleylphosphatidycholine (DOPC) or dipalmitoilphosphatidylcholine: 
cholesterol (1:1 molar, DPPC:Chol) was prepared at a final concentration of 0.3 mM in chloroform. LAURDAN 
Figure 1. Spectral phasor transformation and the three-component analysis. (A) Three spectra for LAURDAN 
(in a low or high polarity environment, blue and green spectra respectively) and for a red fluorescence protein 
(RFP). (B) The Phasor polar plot with the transformed spectral emissions and a single spot for the emission of 
LAURDAN in ordered membrane (Lo), fluid membrane (Ld) and a red fluorescent protein (RFP) (blue, green 
and red dots, respectively). The spectral longer wavelength shift is represented by a counterclockwise shift in the 
phasor plot from the coordinate (1, 0). The spectra of the LAURDAN are shown in an ellipsoid in 1B which is 
colored in a gradient from green (high polarity environment) to blue (low polarity environment). If LAURDAN 
is coexisting with a RFP in the same pixel, then the pixels should fall in a dotted line shown in the picture 
connecting RFP to LAURDAN trajectory.
www.nature.com/scientificreports/
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at 0.5% molar was added to the lipid mixture in chloroform. Then, 4 μL of the organic mixture was applied to the 
each platinum wire and dried under vacuum overnight. The electroformation chamber was filled with 300 μL 
of sucrose 200 mM at 50 °C. To keep the temperature constant we used a circulation bath at 50 °C. For the GUV 
growth, we applied a sinusoidal potential of 2 volts and 10 Hz during 1.5 hours. To detach the GUV from the wire, 
the frequency of the sinusoidal potential was reduced to 1 Hz for 10 min, and then the function generator and 
circulating bath were turned off. For the measurements, 50 ml of the GUVs dispersion were transferred to 8-wells 
bottom-glass imaging chamber containing 300μl of a 200 mM glucose solution. The imaging chamber was coated 
with 1 mg/ml bovine serum albumin (BSA) solution.
Results
LAURDAN Fluorescence. Figure 2 shows the range of LAURDAN fluorescence in DOPC representing Ld 
phase in the membrane (green vesicle) and DPPC: Cholesterol, 1:1 molar (blue vesicle) representing Lo phase in 
the membrane combined with RFP forming a theoretical triangle with the area of the green triangle indicating all 
possible linear combinations.
First we identified the spectral phasor position for differentiated PC12 cells expressing 97Q-mRuby. Figure 3A 
shows a zoomed in region in the phasor plot selecting all the pixels, color coded in pink, corresponding to the 
phasor position of cell expressing mRuby. Next, we characterized membrane fluidity using the spectral phasor 
plot in differentiated PC12 cells stained with LAURDAN (Fig. 3C; average intensity of LAURDAN is shown in the 
inset image). In this case, we used blue and green cursors to identify low to high polar environments sensed by 
LAURDAN. Then we imaged differentiated PC12 cells expressing 97Q-mRuby (Fig. 3D) to show the phasor posi-
tion of LAURDAN emission in the presence of 97Q-mRuby. The position along the Lo to Ld phases are shown 
as a normalized histogram along the blue to green trajectory (Fig. 3E and F). A hypothetical triangle is drawn to 
depict the combination between the possible lipid phase emissions of LAURDAN with the emission of mRuby.
To characterize the cell plasma membrane fluidity, we either applied a threshold or a cell mask to separate 
cell plasma membrane and background as it is shown in supplemental material (Figure S2). Figure 4 shows the 
spectral phasors of differentiated PC12 cells stained with (A) LAURDAN alone, (B) expressing mRuby alone, 
(D) 97Q-mRuby stained with LAURDAN and (E) expressing mRuby stained with LAURDAN. On the corre-
sponding phasor plot (Fig. 4C), the light green cursor identifies the liquid disorder (Ld) phase and the dark blue 
cursor highlights the liquid order (Lo) phase, both connecting to the red cursor (mRuby) to make the theoretical 
triangle, in gray, that encompasses all possible emission species. Figure 4A shows the pseudo-colored highlighted 
image of the PC12 cells stained with LAURDAN where the dark blue cursor in the spectral phasor plot highlights 
the pixels identifying the Lo phase and light green cursor highlights the Ld phase. Note that the cell membranes of 
PC12 cells are highly ordered (dark blue pixels) compared to the inner cellular compartment (light green pixels). 
As it is shown in Fig. 4D, when we have 97Q-mRuby stained with LAURDAN, we observed a shift towards the 
Figure 2. Three component analysis depicting LAURDAN fluorescence emission in Ld/Lo in GUVs and 
mRuby expressing cells (differentiated 97QmRuby). The framework for the three-component analysis is done 
by defining the emission of LAURDAN in the liquid disorder (Ld, DOPC, green GUV) or liquid ordered (Lo, 
DPPC: Cholesterol, 1:1 molar, blue GUV) membranes, and cells expressing the 97Q-mRuby (cell colored by red 
cursor).
www.nature.com/scientificreports/
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liquid disorder phase (Ld) phase (highlighted with dark green pixels) compared to the controls (Fig. 4A and E). 
When we have both mRuby and LAURDAN presents, the spectral phasor coordinates are aligned in the triangle 
connecting the fractional contribution of LAURDAN with mRuby.
To further characterize the membrane stained with LAURDAN, we plotted the normalized histograms of the 
solid to fluid fractions in PC12 cell membranes along the line between green to blue cursor (Fig. 5). When the 
phasor position of mRuby is presented together with LAURDAN, the mixture of the possible components will fall 
inside the theoretical triangle that connects the green/blue cursors and the red cursor. We defined the position 
along the green (Ld) and blue (Lo) trajectory as a fluidity fraction. Supplemental Figures S3 and S4 shows the his-
togram of the fraction of solid to fluid phases on the membrane obtained in the differentiated PC12 cells(control 
line) and in differentiated PC12 cells expressing 97Q-mRuby, respectively.
Figure 5 summarizes the results obtained with LAURDAN. As it is depicted in this summary graph, 
97Q-mRuby histogram is shifted toward increased fluidity in the membrane (Ld phase) compared to the cells 
with LAURDAN alone and LAURDAN-mRuby (controls).
We have also further characterized the histograms shown in Fig. 5 by analyzing the shift in the center of mass, 
termed it as fluidity index, where 0 corresponds to the extreme red spectrum (fluid) and 100 corresponds to the 
extreme blue emission (rigid). The axis is divided linearly according to the linear combination between the Lo and 
Ld phasor coordinates. Figure 6 shows an increase shift in membrane fluidity index for the membrane of PC12 
cells expressing 97QmRuby.
Nile Red Fluorescence. To confirm if the expression of the 97Q was sufficient to cause a spectral shift 
in the plasma membrane, we expressed 97Q with EGFP and used another fluorescent probe, Nile Red, which 
has also shown to be sensitive to the polarity of the lipid environment. NR has an emission peak at 633 nm in 
Phosphatidylcholine (PC) vesicles and an emission spectra at 621 nm in (1:1) PC:Cholesterol vesicles22. For the 
spectral analysis, we determined the fractional contribution of liquid ordered (Lo) versus liquid disordered phases 
(Ld). The emission distribution in each pixel in the image is color coded with two different pseudo-colors within 
the phasor plot: yellow corresponding to low fluidity and blue corresponds to high fluidity in the membrane.
Figure 3. Phasor plot signature for PC12 cell stained with or without LAURDAN. (A) Zoomed region from the 
phasor plot in (B) showing a pink cursor highlighting the spectral emission of mRuby of a differentiated PC12 
cells expressing 97Q-mRuby in the absence of LAURDAN. Using a pink cursor at the phasor plot we can color 
code the pixels at the spectral image (see pseudo color image on the top figure). (C) Differentiated PC 12 cells 
stained with LAURDAN in the absence of mRuby with its corresponding fluidity fraction histogram shown in E. 
The histograms (E&F) indicate the position along the green/trajectory that identifies the fluidity fraction. Here, 
green cursors means high and blue means low fluidity. (D) Differentiated PC12 cells expressing 97Q-mRuby 
stained with LAURDAN. A trajectory representing all the linear combinations between LAURDAN and the 
97Q-mRuby can be seen on the phasor plot. The spectra intensity image is provided on the right side of the 
spectral graph with the corresponding fluidity histogram shown on (F). All Scale bars have a length of 10 μm.
www.nature.com/scientificreports/
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Similar to the experiment with LAURDAN, we applied linear combination properties of the phasor plot to 
characterize membrane fluidity. Supplemental Figures S5 and S6 display the condition when green fluorescent 
protein with or without HTT is expressed in HEK293 cell (Figure S5) and differentiated PC12 cells (Figure S6). 
NR was used to stain the cell and characterize lipid order. In this situation, we identified the location of EGFP 
tagged protein in the spectral phasor, recognized by the cursor shown in green. Then, we calculated the fraction 
of the contributing pixels in the lines connecting the protein (green cursor) to the high/low polarity environment 
for the NR probe (cursors shown in blue and yellow, shown in Figure S6). Supplemental Figure S5, confirm that 
HEK293 cells expressing 97Q-GFP are shifted toward blue in the yellow/blue trajectory that indicates increased 
membrane fluidity (Ld phase).
Similar results indicate a shift toward higher polarity sensed by NR in 97Q-GFP indicating fluid membrane in 
PC12 cells expressing 97Q-GFP compared to 25Q-GFP (control) (Supplemental Figure S6). Supplemental Figure 
S7 summarizes the results shown in bar graph as a normalized fraction of color contribution obtained in this 
section. As it is shown in the bar graphs, control cells have a higher fraction of yellow color (Lo phase) indicating 
highly packed membrane. However in the case of 97Q-GFP, we have higher fraction of blue color (Ld phase) 
indicating the shift toward higher polarity and increased membrane fluidity.
Acute Cholesterol Depletion Influences Cell Membrane Fluidity. To correlate the effect of polyQ 
on cholesterol depletion and modulation of the cell plasma membrane fluidity, cholesterol was depleted by 
methyl-beta-cyclodextrin (MβCD) extracts (Supplemental Figures S8 and S9). Cells were treated with 10 mM 
of MβCD that is well characterized to deplete cholesterol in the membrane34. Previous study indicates decrease 
of up to 70% of cellular cholesterol when cells were treated with 10 mM of MβCD for 10 min35. Following the 
treatment with MβCD, we characterized the LAURDAN stained HEK293 and PC12 cells by spectral time-lapse 
imaging for 45 min. Similar to the shift we observed with 97Q, the shift in membrane fluidity was observed as 
early as 4 min in HEK293 cells and 2 min in PC12 cells indicated by a shift from a membrane fluidity index of 
~70 to ~15. Figures S8 and S9 summarizes the results obtained here in terms of a shift in the fluidity histogram’s 
center of mass analysis.
Discussion
While numerous studies indicate reduction of cholesterol and biosynthesis of fatty acid in HD10,36,37, other 
researchers show interaction of mutant huntingtin with Cav-1,a major cholesterol transporter protein, which 
results in accumulation of cholesterol in neurons12,38. Rising evidence also suggest the role of Huntingtin as a traf-
ficking protein39–41. This suggests that there is a problem with the lipid homeostasis in HD. In this paper, we aimed 
to investigate possible modulation of cell membrane fluidity in HD. For this purpose, we used hyperspectral 
fluorescent microscopy together with the spectral phasor analysis. Two distinct fluorescent dyes (LAURDAN and 
NR) were used to characterize changes in the fluidity of plasma membrane of the cells affected by the expanded 
polyglutamine protein. LAURDAN in particular has been well characterized in the literature and shown to be 
Figure 4. Mapping the emission spectra of LAURDAN and mRuby using spectral Phasor plot in differentiated 
PC12 cells. (A) Differentiated PC12 cells stained with LAURDAN alone are highlighted by the light green 
and dark blue cursors corresponding to the Ld and Lo phases, respectively. The Ld and Lo spectral emission 
coordinates were plotted from DOPC and DPPC GUVs (light green and purple cursors; respectively). (B) 
Shows the red pseudo-color image of mRuby alone. (C) Corresponding Spectral phasor plot are depicted 
here in which the light green (Ld) phase and the purple (Lo) phase are connected to the red cursor (mRuby) 
to make the theoretical triangle of the three pure emission peaks, in gray. As it is shown in D, 97Q-mRuby is 
characterized with increased fluidity in membrane (shift to Ld phase, highlighted in dark green) compared to 
the controls (LAURDAN alone and mRuby + LAURDAN, blue color, Lo phase). Scale bar in images are 10 μm.
www.nature.com/scientificreports/
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sensitive to the lipid order phases due to the lipid composition and the amount of cholesterol present in the 
membranes42,43. The shift we observed in membrane fluidity measured in the HD cells when expanded polyQ 
was expressed may reflect depletion of the cholesterol on the membrane44,45. We have further verified this by 
Figure 5. Normalized histograms of the solid to fluid fractions in PC12 cell membranes. (A) Cells were stained 
with LAURDAN only. (B) PC12 cells expressing mRuby stained with LAURDAN. (C) Histogram of the solid 
to fluid fraction in cells expressing 97Q-mRuby stained with LAURDAN showing a shift toward increased 
membrane fluidity (Ld phase) compared to control lines(top two curves, A&B). Data are averaged for N = 25 for 
LAURDAN-Control, N = 19 for LAURDAN-mRuby-CTR, and N = 16 for 97QmRuby, N = number of the cells, 
standard deviation are represented with error bars.
Figure 6. Fluidity index. Cells expressing 97Q-mRuby have a decrease in membrane fluidity index indicating 
increased membrane fluidity compared to controls.
www.nature.com/scientificreports/
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depleting the cholesterol in cells using MβCD. The results show a sharp shift in emission spectra of LAURDAN 
towards a longer wavelength. This suggests that there may be a possible correlation between the aggregated state 
of expanded polyQ and its lipid interaction at the membrane. Further studies in this area will need to be done to 
elucidate the role of the expanded huntingtin protein and cholesterol regulation.
Our results show a clear shift in membrane fluidity of HD cells from a highly packed membrane, liquid 
ordered, to loosely packed membrane, liquid disordered phase. This shift in fluidity may be implicated in HD 
pathogenesis, and can also be reconciled with following observations: First, research indicates morphological 
and mechanical changes in the synthetic lipid membrane due to the interaction of huntingtin aggregates with the 
membrane46. This implies that that physical interaction of huntingtin aggregates can contribute to the membrane 
fluidity of the cells. Second, the cytotoxic entities of polyQ aggregates that are not eliminated from the cell can 
influence the cell membrane. It has been shown that dysregulation of fatty acids disrupts autophagy in the cell, the 
lysosomal degradation pathway essential for cell survival47. This is important as autophagic failure is the hallmark 
of HD and other neurodegenerative diseases48. Failure to induce autophagosome in HD allows for the accumu-
lation of the polyQ aggregate forming many toxic small aggregates and large insoluble inclusions that can affect 
cell membrane. Finally, modulation of fatty acid can directly modify the structure of the lipid membrane and 
alter micro-domain structure and organization that can be the origin of altered cell signaling49. Not surprisingly, 
alteration of endocannabinoids (eCBS), a powerful regulator of synaptic function signaling has been reported in 
Huntington disease and other similar neurodegenerative diseases, and it is also believed that this altered eCBs 
signaling is due to changes in the cell membrane environment with research focused on therapeutic drugs to 
modulate the eCBs activity50,51. Together, our measurements on the fluidity properties of membranes in HD cells 
shows for the first time that expanded polyQ results in an increased membrane fluidity which c influence other 
membrane properties such as lipid domain sequestering, ion transport, receptor dynamics, cell to cell contact, 
and membrane trafficking52–54.
The methodologies described in this paper can be used as a platform for better understating of HD and similar 
neurodegenerative disorders. It also provides a powerful mean to characterize small changes in the membrane 
microenvironment. This study demonstrates that changes in membrane fluidity can be used as a biomarker for 
Huntingtin Disease. In addition, the spectral phasors presented in this article, can also rapidly and non-invasively 
screen for the efficacy of lipid membrane therapies.
Conclusion
Cell membrane degradation, and defects in membrane trafficking is the hallmark of many neurodegenerative 
diseases. Here, we have characterized the fluidity in the cell plasma membrane of the HD cells using two distinct 
membrane probes: LAURDAN and NR in conjunction with spectral phasor analysis. Our investigations indicate 
alteration in plasma membrane homeostasis that is relevant as it can play a role in cell death, and also can affect 
control mechanism of ions and molecular transport. We observed a sharp shift using spectral phasor analysis in 
LAURDAN emission toward longer wavelength indicating increased fluid membrane in HD in both HEK 293 
cells and differentiated PC12 cells. As previously discussed, increased membrane fluidity observed here can be 
related to the observation due to alteration of biosynthesis of fatty acid or disruption of transport mechanism of 
lipid in HD. In addition, mHTT toxicity through physical or biochemical means can also result in the cell mem-
brane defects reported here. Such alternation in membrane fluidity can be used as a HD biomarker and also for 
future drug discovery.
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